Concepedia

Samantha Bucktrout

SB

Statistics

Publications

11

Citations

2.5K

H-Index

11

Active since

2019

Affiliations

Parker Institute for Cancer Immunotherapy(Current)

Stanford University

University of California, San Francisco

The University of Texas MD Anderson Cancer Center

University of California, Los Angeles

Samantha Bucktrout is an author at Parker Institute for Cancer Immunotherapy specializing in oncology, medicine, and cancer therapeutics.

Top concepts

Publications per year

2019–2022

11

Publications

11

Clonal replacement of tumor-specific T cells following PD-1 blockade

Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells et al. · Nature Medicine · 2019 · 1.5K citations

, , +6

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 316 citations · Full text

, , +13

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary et al. · The Lancet Oncology · 2020 · 286 citations

, , +7

Clonal replacement of tumor-specific T cells following PD-1 blockade

Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells et al. · 2019 · 163 citations · Full text

Characterization and Comparison of GITR Expression in Solid Tumors

Luis M. Vence, Samantha Bucktrout, Irina Fernandez Curbelo et al. · Clinical Cancer Research · 2019 · 59 citations · Full text

1–5 of 11